drugset / Trial / NCT00434213
Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA
NaSingle-groupOpen-labelTreatment
Summary
This is a study designed to characterize the dermal response of DAYTRANA. Subjects will visit the study site over a period of approximately 14 weeks.
Timeline
- Start
- 2007-01
- Primary completion
- 2007-08
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 10 mg | Topical |
| Subject | Methylphenidate | Small molecule | 15 mg | Topical |
| Subject | Methylphenidate | Small molecule | 20 mg | Topical |
| Subject | Methylphenidate | Small molecule | 30 mg | Topical |